Bristol-Myers Squibb Company
Utility Patent Applications
Last updated:
List of all Bristol-Myers Squibb Company patents 438 in total
| Status | Patent |
|---|---|
Application | Utility: GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISORDERS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 28 Oct 2021 |
Application | Utility: ANTIBODIES TO TIGIT Filling date: 6 Sep 2025 Issue date: 21 Oct 2021 |
Application | Utility: TREATMENT OF LUNG CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND ANOTHER ANTI-CANCER AGENT Filling date: 6 Sep 2025 Issue date: 21 Oct 2021 |
Application | Utility: TETRAHYDROPYRAN-BASED THIODISACCHARIDE MIMICS AS GALECTIN-3 INHIBITORS Filling date: 6 Sep 2025 Issue date: 21 Oct 2021 |
Application | Utility: IMIDAZOPYRIDAZINE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 21 Oct 2021 |
Application | Utility: OXABICYCLO ACIDS AS LPA ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 14 Oct 2021 |
Application | Utility: INDAZOLE CARBOXAMIDES AS KINASE INHIBITORS Filling date: 6 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: PROTEIN FRAGMENTATION CONTROL STRATEGY BY RE-OXIDATION IN DOWNSTREAM CHROMATOGRAPHY Filling date: 6 Sep 2025 Issue date: 30 Sep 2021 |
Application | Utility: METHODS FOR DETECTING ANTI-DRUG ANTIBODIES Filling date: 6 Sep 2025 Issue date: 30 Sep 2021 |
Application | Utility: INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE Filling date: 6 Sep 2025 Issue date: 30 Sep 2021 |
Application | Utility: INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE Filling date: 6 Sep 2025 Issue date: 23 Sep 2021 |
Application | Utility: DIMETHOXYPHENYL SUBSTITUTED INDOLE COMPOUNDS AS TLR7, TLR8 OR TLR9 INHIBITORS Filling date: 6 Sep 2025 Issue date: 23 Sep 2021 |
Application | Utility: COMPOSITIONS COMPRISING AN ANTI-LAG-3 ANTIBODY OR AN ANTI-LAG-3 ANTIBODY AND AN ANTI-PD-1 OR ANTI-PD-L1 ANTIBODY Filling date: 6 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE Filling date: 6 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: BIARYL KINASE INHIBITORS Filling date: 6 Sep 2025 Issue date: 9 Sep 2021 |
Application | Utility: FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND PCSK9 Filling date: 6 Sep 2025 Issue date: 9 Sep 2021 |
Application | Utility: OX-40 AGONIST, PD-1 PATHWAY INHIBITOR AND CTLA-4 INHIBITOR COMBINATION FOR USE IN A METHOD OF TREATING A CANCER OR A SOLID TUMOR Filling date: 6 Sep 2025 Issue date: 9 Sep 2021 |
Application | Utility: NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS Filling date: 6 Sep 2025 Issue date: 9 Sep 2021 |
Application | Utility: PROCESS FOR PREPARING INDOLE CARBOXAMIDE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 9 Sep 2021 |
Application | Utility: SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS Filling date: 6 Sep 2025 Issue date: 26 Aug 2021 |
Application | Utility: FGF-21 FORMULATIONS Filling date: 6 Sep 2025 Issue date: 26 Aug 2021 |
Application | Utility: TREATMENT OF LAG-3 POSITIVE TUMORS Filling date: 6 Sep 2025 Issue date: 26 Aug 2021 |
Application | Utility: SULFONE PYRIDINE ALKYL AMIDE-SUBSTITUTED HETEROARYL COMPOUNDS Filling date: 6 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: METHODS OF PRODUCING RECOMBINANT PROTEINS Filling date: 6 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: SINGLE PASS TANGENTIAL FLOW FILTRATION HYBRID CONFIGURATIONS FOR ENHANCING CONCENTRATION OF MACROMOLECULE SOLUTIONS Filling date: 6 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: SUBSTITUTED INDOLE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS Filling date: 6 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: CARBAMOYLOXYMETHYL TRIAZOLE CYCLOHEXYL ACIDS AS LPA ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 12 Aug 2021 |
Application | Utility: CYCLOBUTANES- AND AZETIDINE-CONTAINING MONO AND SPIROCYCLIC COMPOUNDS AS ALPHA V INTEGRIN INHIBITORS Filling date: 6 Sep 2025 Issue date: 12 Aug 2021 |
Application | Utility: METHODS OF PURIFYING PROTEINS Filling date: 6 Sep 2025 Issue date: 12 Aug 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR PRODUCING A COMPOSITION Filling date: 6 Sep 2025 Issue date: 12 Aug 2021 |
Application | Utility: LAG-3 Combination Therapy for the Treatment of Cancer Filling date: 6 Sep 2025 Issue date: 5 Aug 2021 |
Application | Utility: CYCLOHEXYL ACID TRIAZOLE AZINES AS LPA ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: ANTIBODIES TO ALPHA-SYNUCLEIN AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 22 Jul 2021 |
Application | Utility: COMPOSITIONS COMPRISING BISFLUOROALKYL-1,4-BENZODIAZEPINONE COMPOUNDS AND METHODS OF USE THEREOF Filling date: 6 Sep 2025 Issue date: 22 Jul 2021 |
Application | Utility: INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE Filling date: 6 Sep 2025 Issue date: 22 Jul 2021 |
Application | Utility: CRYSTALLINE FORM OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-- YL)PHENYL)AMINO)-N-(METHYL-D3) PYRIDAZINE-3-CARBOXAMIDE Filling date: 6 Sep 2025 Issue date: 8 Jul 2021 |
Application | Utility: INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE Filling date: 6 Sep 2025 Issue date: 8 Jul 2021 |
Application | Utility: TREATMENT OF LUNG CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND ANOTHER ANTI-CANCER AGENT Filling date: 6 Sep 2025 Issue date: 8 Jul 2021 |
Application | Utility: MODIFIED RELAXIN POLYPEPTIDES COMPRISING A PHARMACOKINETIC ENHANCER AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 1 Jul 2021 |
Application | Utility: IMAGING METHODS USING 18F-RADIOLABELED BIOLOGICS Filling date: 6 Sep 2025 Issue date: 1 Jul 2021 |
Application | Utility: APELIN RECEPTOR AGONISTS AND METHODS OF USE Filling date: 6 Sep 2025 Issue date: 1 Jul 2021 |
Application | Utility: TL1A ANTIBODIES AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: 3-SUBSTITUTED PROPIONIC ACIDS AS ALPHA V INTEGRIN INHIBITORS Filling date: 6 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: TRICYCLIC HETEROARYL-SUBSTITUTED QUINOLINE AND AZAQUINOLINE COMPOUNDS AS PAR4 INHIBITORS Filling date: 6 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: SUBSTITUTED BICYCLIC COMPOUNDS USEFUL AS T CELL ACTIVATORS Filling date: 6 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: DIAZASPIRO ROCK INHIBITORS Filling date: 6 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: Antisense Oligonucleotides Targeting Alpha-Synuclein and Uses Thereof Filling date: 6 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: ALKENE SPIROCYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS Filling date: 6 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: IMPROVED PROTEIN RECOVERY Filling date: 6 Sep 2025 Issue date: 10 Jun 2021 |
Showing 100 to 150 of 438 patents.